retatrutide or tirzepatide vs Tirzepatide: GLP-1, GIP & Glucagon Retatrutide vs Tirzepatide vs Semaglutide

References 1.Shi I., Khan S.S., Yeh R.W., Ho J.E., Dahabreh I.J., Kazi D.S

Still, Skovronsky said, "I think we're making history here, both on the high end with the high dose and on the low dose for what we can offer patients." "For some patients, 30% weight loss may be more than what they're seeking," Skovronsky later added

Sustainability Concerns : The requirement for potentially lifelong therapy, combined with rapid weight regain upon discontinuation, raises questions about long-term sustainability and practical implementation

Another logistical issue with injectable GLP-1 drugs is that they require refrigeration throughout the supply chain